Drag a card by its title · ⚙ to size, swap or remove

The company

4D Molecular Therapeutics, Inc.

FDMT · Nasdaq

Health CareBiotechnologyLeading

FDMT stood above a rising 150-day average in 40 of the last 52 weekly readings, including each of the last 16 weeks. It is 15.0% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 16 in a row
Industry in uptrend: 18% -14 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $9.9M
Officials’ trades on record: 0
Institutions holding: 151 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 40 of 52 weeks.

21 Apr – 20 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months21

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Scott BizilyChief Legal Officer	sold	1,635at $12.84	16 Oct 2026filed 20 Oct 2026
David KirnDirector, Officer	sold	58,061at $12.92	5 Oct 2026filed 7 Oct 2026
David KirnDirector, Officer	sold	272at $13.61	5 Oct 2026filed 7 Oct 2026
Scott BizilyChief Legal Officer	sold	1,635at $13.65	16 Sep 2026filed 22 Sep 2026
David KirnDirector, Officer	sold	58,333at $13.90	14 Sep 2026filed 16 Sep 2026
Scott BizilyChief Legal Officer	sold	584at $14.00	1 Sep 2026filed 3 Sep 2026
David KirnDirector, Officer	sold	43,149at $15.36	19 Aug 2026filed 21 Aug 2026
David KirnDirector, Officer	sold	25,927at $16.42	19 Aug 2026filed 21 Aug 2026
Scott BizilyChief Legal Officer	sold	1,635at $12.20	17 Aug 2026filed 17 Aug 2026
Scott BizilyChief Legal Officer	sold	1,635at $12.00	13 Aug 2026filed 17 Aug 2026
David KirnDirector, Officer	sold	26,842at $10.23	4 Aug 2026filed 5 Aug 2026
David KirnDirector, Officer	sold	12,415at $10.05	3 Aug 2026filed 4 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders151+11 on the quarter

New · exited36 · 24

Reported value$738.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Jupiter Topco LLCnew · filed 14 Aug 2026	5,746,289$76.5M	+5,746,289
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	5,049,779$67.2M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	4,546,059$60.5M	+400,756+9.7%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	4,258,668$56.6M	+53,230+1.3%
NOVO HOLDINGS A/Sreduced · filed 14 Aug 2026	3,249,178$43.2M	-401,559−11.0%
STATE STREET CORPadded · filed 7 Aug 2026	2,911,109$38.7M	+203,234+7.5%
BVF INCunchanged · filed 14 Aug 2026	2,879,289$38.3M	00.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	2,249,203$29.9M	+644,047+40.1%
Trails Edge Capital Partners, LPadded · filed 14 Aug 2026	2,227,917$29.6M	+925,000+71.0%
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026	2,099,055$27.9M	+2,099,055